Cresset biomolecular discovery LTD:1262990 [22-001727]
Ended Purchase Order Awarded
- Contract number
- 75N95022P00141
- Awardee
-
Cresset Biomolecular Discovery LIMITED UEI YFVNHK9FS147
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $45,585
Award facts
- Opportunity
-
- Renewal of License subscription to access Flare LigandPro, Forge GUI, Spark GUI and Engine Broker 5-User Group Software Solicitation · 75N95022Q00116 · Posted Feb 11, 2022
- Contract value 100% obligated
- $45,585.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 511210 Software Publishers
- PSC
- R499 Support- Professional: Other
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Great Britain, United Kingdom
Award details come from SAM.gov/FPDS.
Quick answers
Who was awarded contract 75N95022P00141?
75N95022P00141 was awarded to Cresset Biomolecular Discovery LIMITED by National Institute on Drug Abuse (National Institutes of Health) on March 11, 2022.
How much is contract 75N95022P00141 worth?
The government has obligated $45,585 on 75N95022P00141.
Was contract 75N95022P00141 competed?
The extent of competition for 75N95022P00141 was competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award